Cargando…
Differential diffusion of pharmaceutical innovations in a mixed market middle - income economy
BACKGROUND: Policymakers are faced with the challenge of balancing patient’s access for effective and affordable medicines to sustain the rising healthcare costs. In a mixed healthcare market such as Malaysia, coverage decisions of new medicines are different: public funded health system has a formu...
Autores principales: | Md Hamzah, Nurhafiza, See, Kok Fong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524869/ https://www.ncbi.nlm.nih.gov/pubmed/34663311 http://dx.doi.org/10.1186/s12913-021-06786-6 |
Ejemplares similares
-
Assessing the efficiency of Malaysia health system in COVID-19 prevention and treatment response
por: Md Hamzah, Nurhafiza, et al.
Publicado: (2021) -
Pharmaceutical innovation and access to financial markets
por: Blau, Benjamin M., et al.
Publicado: (2022) -
National Innovation Systems in Low-Income and Middle-Income Countries: Re-evaluation of Indicators and Lessons for a Learning Economy in Senegal
por: Casadella, Vanessa, et al.
Publicado: (2022) -
Effect of Patent Expiry on the Performance of Innovator Multinational Pharmaceutical Companies in a Low Middle Income Country
por: Khalil, Farrukh, et al.
Publicado: (2022) -
Differentiate or die: reconstructing market(place) economies
por: Morales, Alfonso
Publicado: (2020)